The current study generated a 27-gene classifier to explore differences in terms of molecular, histological, and clinical bladder cancer subtypes, clinical risk categories, T-stage categories, pathologic grade, PD-L1 expression, and cancer-specific survival in a cohort series of 107 urothelial carcinomas of the bladder. The gene discussed is CD274; the disease is urinary bladder cancer.